







IMPORTANT!
THE PRICE OF THE TEST INCLUDES A DNA SAMPLE COLLECTION KIT.
The Apixmed Prism Lipids, Cholesterol and Fatty Acids genetic test covers 50 markers across seven areas of lipid metabolism, including 33 complex markers and 17 individual genetic variants in 13 genes.
A DNA kit for collecting your saliva sample yourself is already included in the price of the test.
Genotyping of the sample in an accredited laboratory.
A report explaining 50 markers and genetic variants in plain language, with an interpretation of the results:
33 polygenic (complex) traits with an explanation of your individual result and what it means;
17 individual genetic variants with an explanation of their possible biological significance.
Context for every marker: genetics is not considered in isolation from lifestyle, age, environment and other factors.
Personalized recommendations on nutrition, physical activity, sleep, lifestyle and preventive approaches.
The option of a consultation with an Apixmed Prism specialist based on your report results.
Pointers to potentially relevant laboratory or clinical parameters that you can discuss with your doctor.
Data protection in line with ISO 27001, GDPR and HIPAA standards.
The Lipids, Cholesterol and Fatty Acids genetic test covers seven areas, within which it analyzes 33 complex markers and 17 individual genetic variants in 13 genes: from omega-3 and omega-6 fatty acids to the cholesterol, triglyceride and apolipoprotein profile. It assesses how your genetic profile and individual genetic variants are associated with relatively higher or lower levels of fatty acids and lipids compared with a reference population. The test does not measure the concentration of any substance in the blood — instead it examines the stable genetic context that complements a lipid panel and other laboratory tests rather than replacing them.
DNA sample collection is done using saliva. You receive the kit by post and collect your own DNA sample into a special tube — it takes just a few minutes and requires no preparation. The sample is then sent for analysis to an accredited laboratory, and you receive your result in digital format.
33 markers across seven areas. Assessed using polygenic risk scores: tens and hundreds of variants together shape the contribution to a predisposition, and no single one of them determines the picture on its own.
Omega-3 fatty acids: alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA)
Omega-6 fatty acids and balance: omega-6 fatty acids, linoleic acid (LA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), arachidonic acid (ARA), omega-6/omega-3 ratio
Fatty acid classes and chain length: saturated fatty acids (SFA), very-long-chain saturated fatty acids (VLC-SFA), monounsaturated fatty acids (MUFA), oleic acid
Bioactive lipids and related compounds: coenzyme Q10, choline, ceramide
Cholesterol and triglyceride profile: total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, non-HDL cholesterol, very-low-density lipoprotein (VLDL) cholesterol, remnant cholesterol
Apolipoproteins and lipoprotein particles: apolipoprotein A-I, apolipoprotein B (ApoB), apolipoprotein B-to-apolipoprotein A-I ratio, lipoprotein(a) [Lp(a)], HDL particle size, LDL particle size
Lipid metabolism disorders: hyperlipidemia, hypercholesterolemia, hypertriglyceridemia
17 genetic variants in 13 genes. A mechanistic link to the trait is described for each, so they are interpreted individually and are not included in the complex markers.
ELOVL2: elongation of long-chain polyunsaturated fatty acids (PUFAs)
FADS1 and FADS2: desaturases that convert short-chain omega-3 and omega-6 precursors into long-chain forms (EPA, DHA, ARA), three variants
ABCA1: cholesterol efflux from cells, associated with HDL cholesterol
CETP and LIPC: associated with HDL cholesterol levels
ANGPTL4: an inhibitor of lipoprotein lipase, associated with triglycerides
APOA5: two variants associated with triglyceride levels
GCKR: regulation of glucose and lipid metabolism in the liver, associated with triglycerides
LPL: breakdown of triglycerides carried in lipoproteins, associated with triglycerides and HDL cholesterol
APOA2: associated with how the lipid profile responds to dietary saturated fat
PCSK9: regulation of LDL receptors, associated with LDL cholesterol
LPA: apolipoprotein(a) synthesis, two variants associated with lipoprotein(a) levels more strongly than any other in this test
Family history of high cholesterol or early cardiac events: specific genetic context for a conversation with your doctor.
Borderline lipid panel results: additional context for prioritizing prevention together with your doctor.
Interest in dietary omega-3: genetic context on how efficiently plant-based precursors are converted to EPA and DHA.
When choosing supplements: a reason to discuss whether they are appropriate with your doctor, not grounds to change anything on your own.
The Lipids, Cholesterol and Fatty Acids test is not a diagnosis and does not replace consultation with a doctor.
The results assess probability rather than establishing a predetermined outcome. They are not a diagnosis, do not confirm a disease and do not determine treatment. The test does not replace a lipid panel or other laboratory tests. Clinical decisions are made by a specialist, taking into account your history, symptoms, diet, age, medication and laboratory data.